Screening, endpoint classification, and safety monitoring in the Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

European Journal of Heart Failure

Volumn 2, Issue 3, 2000, Pages 315-324

  Fagerberg, Björn ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Endpoint classification; Safety monitoring; Screening

Indexed keywords

METOPROLOL; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG INDICATION; DRUG SAFETY; FEMALE; HEART EJECTION FRACTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL RESEARCH; METHODOLOGY; MULTICENTER STUDY; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCREENING TEST; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; DOUBLE-BLIND METHOD; DRUG MONITORING; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; METOPROLOL; MIDDLE AGED; PATIENT SELECTION; SAFETY; SURVIVAL RATE;

EID: 0033857312     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(00)00101-X     Document Type: Article

References (23)

1. Monitoring of clinical trials: Issues and recommendations
2. Consecutive screening and enrollment in clinical studies: The way to representative patient samples?
3. Mode of death in chronic heart failure. A request and proposition for more accurate classification
4. The impact of an end-point committee in a large multicentre, randomized, placebo-controlled clinical trial
5. Disagreement between site investigators and clinical event committees is common and can affect trial results
6. The early termination of clinical trials: Causes, consequences, and control
7. Rationale, design, and organisation of the metoprolol CR/XL randomized trial in heart failure (MERIT-HF)
8. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF)
9. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: The metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF)
10. Repeated assessments of results in clinical trials of cancer treatment
11. Design and analysis of randomized clinical trials requiring prolonged observations of each patient. I. Introduction and design
12. Discrete sequential boundaries for clinical trials
13. Epidemiology of heart failure and ventricular dysfunction
14. Effects of enalapril on mortality in severe congestive heart failure
15. The cardiac insufficiency bisoprolol study II (CIBIS-II): A randomised trial
16. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
17. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial
18. Sequential trials, sequential analysis, and the likelihood principal
19. Repeated significance tests on accumulating data
20. Statistics: The problem of examining accumulating data more than once
21. Group sequential methods in the design and analysis of clinical trials
22. Interim analyses for randomized clinical trials: The group sequential approach